85 related articles for article (PubMed ID: 28990552)
1. [Mitochondria link between cannabinoid and memory].
Hébert-Chatelain É; Marsicano G
Med Sci (Paris); 2017; 33(6-7):579-581. PubMed ID: 28990552
[No Abstract] [Full Text] [Related]
2. A cannabinoid link between mitochondria and memory.
Hebert-Chatelain E; Desprez T; Serrat R; Bellocchio L; Soria-Gomez E; Busquets-Garcia A; Pagano Zottola AC; Delamarre A; Cannich A; Vincent P; Varilh M; Robin LM; Terral G; García-Fernández MD; Colavita M; Mazier W; Drago F; Puente N; Reguero L; Elezgarai I; Dupuy JW; Cota D; Lopez-Rodriguez ML; Barreda-Gómez G; Massa F; Grandes P; Bénard G; Marsicano G
Nature; 2016 Nov; 539(7630):555-559. PubMed ID: 27828947
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cannabinoid signaling by hippocampal 5-HT4 serotonergic system in fear conditioning.
Nasehi M; Farrahizadeh M; Ebrahimi-Ghiri M; Zarrindast MR
J Psychopharmacol; 2016 Sep; 30(9):936-44. PubMed ID: 27296273
[TBL] [Abstract][Full Text] [Related]
4. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
Breivogel CS; Vaghela MS
J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
[TBL] [Abstract][Full Text] [Related]
5. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
Ribeiro R; Wen J; Li S; Zhang Y
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
[TBL] [Abstract][Full Text] [Related]
6. The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.
Giné E; Echeverry-Alzate V; Lopez-Moreno JA; Rodriguez de Fonseca F; Perez-Castillo A; Santos A
Neuropharmacology; 2017 Apr; 116():132-141. PubMed ID: 28017790
[TBL] [Abstract][Full Text] [Related]
7. Roles of the endocannabinoid system in learning and memory.
Marsicano G; Lafenêtre P
Curr Top Behav Neurosci; 2009; 1():201-30. PubMed ID: 21104385
[TBL] [Abstract][Full Text] [Related]
8. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.
Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798
[TBL] [Abstract][Full Text] [Related]
9. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
10. CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice.
Kruk-Slomka M; Biala G
Behav Brain Res; 2016 Mar; 301():84-95. PubMed ID: 26711911
[TBL] [Abstract][Full Text] [Related]
11. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135.
De Luca MA; Castelli MP; Loi B; Porcu A; Martorelli M; Miliano C; Kellett K; Davidson C; Stair JL; Schifano F; Di Chiara G
Neuropharmacology; 2016 Jun; 105():630-638. PubMed ID: 26686391
[TBL] [Abstract][Full Text] [Related]
12. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review.
Kruk-Slomka M; Dzik A; Budzynska B; Biala G
Mol Neurobiol; 2017 Dec; 54(10):8332-8347. PubMed ID: 27924524
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of cannabinoid receptor agonists and a cyclooxygenase-2 inhibitor in rat bone tumor pain.
Cui JH; Ju J; Yoon MH
Pharmacology; 2013; 92(3-4):150-7. PubMed ID: 24008428
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture.
Jackson SJ; Baker D; Cuzner ML; Diemel LT
Eur J Neurosci; 2004 Nov; 20(9):2267-75. PubMed ID: 15525268
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
Laprairie RB; Kelly ME; Denovan-Wright EM
Neuropharmacology; 2013 Sep; 72():47-57. PubMed ID: 23602984
[TBL] [Abstract][Full Text] [Related]
18. CB
Saravia R; Flores Á; Plaza-Zabala A; Busquets-Garcia A; Pastor A; de la Torre R; Di Marzo V; Marsicano G; Ozaita A; Maldonado R; Berrendero F
Biol Psychiatry; 2017 Apr; 81(7):625-634. PubMed ID: 27737762
[TBL] [Abstract][Full Text] [Related]
19. Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors.
García-Gutiérrez MS; Ortega-Álvaro A; Busquets-García A; Pérez-Ortiz JM; Caltana L; Ricatti MJ; Brusco A; Maldonado R; Manzanares J
Neuropharmacology; 2013 Oct; 73():388-96. PubMed ID: 23796670
[TBL] [Abstract][Full Text] [Related]
20. Glucose metabolism links astroglial mitochondria to cannabinoid effects.
Jimenez-Blasco D; Busquets-Garcia A; Hebert-Chatelain E; Serrat R; Vicente-Gutierrez C; Ioannidou C; Gómez-Sotres P; Lopez-Fabuel I; Resch-Beusher M; Resel E; Arnouil D; Saraswat D; Varilh M; Cannich A; Julio-Kalajzic F; Bonilla-Del Río I; Almeida A; Puente N; Achicallende S; Lopez-Rodriguez ML; Jollé C; Déglon N; Pellerin L; Josephine C; Bonvento G; Panatier A; Lutz B; Piazza PV; Guzmán M; Bellocchio L; Bouzier-Sore AK; Grandes P; Bolaños JP; Marsicano G
Nature; 2020 Jul; 583(7817):603-608. PubMed ID: 32641832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
